According to Raymond James, the prior rating for Lennar Corp (NYSE:LEN) was changed from Market Perform to Outperform. Lennar earned $2.94 in the second quarter, compared to $4.69 in the year-ago quarter. The current stock performance of Lennar shows a 52-week-high of $130.46 and a 52-week-low of $69.97. Moreover, at the end of the last trading period, the closing price was at $130.08.

UBS upgraded the previous rating for Microsoft Corp (NASDAQ:MSFT) from Neutral to Buy. Microsoft earned $2.45 in the third quarter, compared to $2.22 in the year-ago quarter. The current stock performance of Microsoft shows a 52-week-high of $351.47 and a 52-week-low of $213.46. Moreover, at the end of the last trading period, the closing price was at $342.66.

According to Chardan Capital, the prior rating for Ouster Inc (NYSE:OUST) was changed from Neutral to Buy. For the first quarter, Ouster had an EPS of $2.65, compared to year-ago quarter EPS of $1.90. The current stock performance of Ouster shows a 52-week-high of $20.85 and a 52-week-low of $3.21. Moreover, at the end of the last trading period, the closing price was at $6.23.

According to Morgan Stanley, the prior rating for Boyd Gaming Corp (NYSE:BYD) was changed from Underweight to Equal-Weight. Boyd Gaming earned $1.71 in the first quarter, compared to $1.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $71.69 and a 52-week-low of $46.10. Boyd Gaming closed at $71.43 at the end of the last trading period.

According to Raymond James, the prior rating for Ero Copper Corp (NYSE:ERO) was changed from Outperform to Market Perform. In the first quarter, Ero Copper showed an EPS of $0.24, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.46 and a 52-week-low of $8.17. Ero Copper closed at $22.37 at the end of the last trading period.

Truist Securities downgraded the previous rating for American Equity Investment Life Holding Co (NYSE:AEL) from Buy to Hold. For the first quarter, American Equity Inv had an EPS of $1.47, compared to year-ago quarter EPS of $0.92. At the moment, the stock has a 52-week-high of $53.68 and a 52-week-low of $28.09. American Equity Inv closed at $53.34 at the end of the last trading period.

Guggenheim downgraded the previous rating for Leslies Inc (NASDAQ:LESL) from Buy to Neutral. For the second quarter, Leslies had an EPS of $0.14, compared to year-ago quarter EPS of $0.01. The current stock performance of Leslies shows a 52-week-high of $17.12 and a 52-week-low of $9.03. Moreover, at the end of the last trading period, the closing price was at $9.52.

Raymond James downgraded the previous rating for EPR Properties (NYSE:EPR) from Strong Buy to Outperform. In the first quarter, EPR Props showed an EPS of $1.26, compared to $1.10 from the year-ago quarter. The current stock performance of EPR Props shows a 52-week-high of $55.90 and a 52-week-low of $33.92. Moreover, at the end of the last trading period, the closing price was at $45.98.

For Theseus Pharmaceuticals Inc (NASDAQ:THRX), Needham downgraded the previous rating of Buy to Hold. In the first quarter, Theseus Pharmaceuticals showed an EPS of $0.34, compared to $0.27 from the year-ago quarter. The current stock performance of Theseus Pharmaceuticals shows a 52-week-high of $14.77 and a 52-week-low of $4.50. Moreover, at the end of the last trading period, the closing price was at $9.52.

For First Wave BioPharma Inc (NASDAQ:FWBI), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. For the fourth quarter, First Wave BioPharma had an EPS of $9.47, compared to year-ago quarter EPS of $35.70. The stock has a 52-week-high of $49.35 and a 52-week-low of $0.79. At the end of the last trading period, First Wave BioPharma closed at $0.91.

Wells Fargo downgraded the previous rating for Progressive Corp (NYSE:PGR) from Overweight to Equal-Weight. In the second quarter, Progressive showed an EPS of $0.40, compared to $1.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $149.87 and a 52-week-low of $109.42. Progressive closed at $114.78 at the end of the last trading period.

JP Morgan downgraded the previous rating for AT&T Inc (NYSE:T) from Overweight to Neutral. In the first quarter, AT&T showed an EPS of $0.60, compared to $0.63 from the year-ago quarter. The current stock performance of AT&T shows a 52-week-high of $22.84 and a 52-week-low of $14.47. Moreover, at the end of the last trading period, the closing price was at $15.12.

According to Needham, the prior rating for Inogen Inc (NASDAQ:INGN) was changed from Buy to Hold. Inogen earned $0.63 in the first quarter, compared to $0.39 in the year-ago quarter. The current stock performance of Inogen shows a 52-week-high of $32.01 and a 52-week-low of $9.55. Moreover, at the end of the last trading period, the closing price was at $10.26.

With a Equal-Weight rating, Capital One initiated coverage on Chart Industries Inc (NYSE:GTLS). The price target seems to have been set at $174.00 for Chart Industries. In the first quarter, Chart Industries showed an EPS of $1.41, compared to $0.65 from the year-ago quarter. The current stock performance of Chart Industries shows a 52-week-high of $242.00 and a 52-week-low of $101.44. Moreover, at the end of the last trading period, the closing price was at $164.50.

With a Equal-Weight rating, Capital One initiated coverage on NOV Inc (NYSE:NOV). The price target seems to have been set at $20.00 for NOV. For the first quarter, NOV had an EPS of $0.32, compared to year-ago quarter EPS of $0.13. The current stock performance of NOV shows a 52-week-high of $24.83 and a 52-week-low of $13.98. Moreover, at the end of the last trading period, the closing price was at $18.48.

With an Overweight rating, Capital One initiated coverage on ChampionX Corp (NASDAQ:CHX). The price target seems to have been set at $40.00 for ChampionX. ChampionX earned $0.36 in the first quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.41 and a 52-week-low of $16.78. ChampionX closed at $34.02 at the end of the last trading period.

With a Buy rating, CL King initiated coverage on EnerSys (NYSE:ENS). The price target seems to have been set at $137.00 for EnerSys. For the fourth quarter, EnerSys had an EPS of $1.82, compared to year-ago quarter EPS of $1.20. At the moment, the stock has a 52-week-high of $111.80 and a 52-week-low of $55.81. EnerSys closed at $110.99 at the end of the last trading period.

Stephens & Co. initiated coverage on Apyx Medical Corp (NASDAQ:APYX) with an Overweight rating. The price target for Apyx Medical is set to $8.00. Apyx Medical earned $0.10 in the first quarter, compared to $0.17 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.07 and a 52-week-low of $1.31. Apyx Medical closed at $6.07 at the end of the last trading period.

With an Overweight rating, Piper Sandler initiated coverage on Black Diamond Therapeutics Inc (NASDAQ:BDTX). The price target seems to have been set at $11.00 for Black Diamond Therapeutic. In the first quarter, Black Diamond Therapeutic showed an EPS of $0.57, compared to $0.70 from the year-ago quarter. The current stock performance of Black Diamond Therapeutic shows a 52-week-high of $6.85 and a 52-week-low of $1.18. Moreover, at the end of the last trading period, the closing price was at $4.91.

With an In-Line rating, Evercore ISI Group initiated coverage on ESAB Corp (NYSE:ESAB). The price target seems to have been set at $75.00 for ESAB. ESAB earned $1.10 in the first quarter, compared to $1.17 in the year-ago quarter. The current stock performance of ESAB shows a 52-week-high of $69.89 and a 52-week-low of $32.20. Moreover, at the end of the last trading period, the closing price was at $69.11.

With an Outperform rating, Hovde Group initiated coverage on South Plains Financial Inc (NASDAQ:SPFI). The price target seems to have been set at $28.00 for South Plains Financial. For the first quarter, South Plains Financial had an EPS of $0.53, compared to year-ago quarter EPS of $0.78. At the moment, the stock has a 52-week-high of $31.89 and a 52-week-low of $18.75. South Plains Financial closed at $23.84 at the end of the last trading period.

HSBC initiated coverage on Merck & Co Inc (NYSE:MRK) with a Hold rating. The price target for Merck & Co is set to $123.00. Merck & Co earned $1.40 in the first quarter, compared to $2.14 in the year-ago quarter. The stock has a 52-week-high of $119.65 and a 52-week-low of $84.52. At the end of the last trading period, Merck & Co closed at $106.32.

With a Reduce rating, HSBC initiated coverage on Bristol-Myers Squibb Co (NYSE:BMY). The price target seems to have been set at $56.00 for Bristol-Myers Squibb. Bristol-Myers Squibb earned $2.05 in the first quarter, compared to $1.96 in the year-ago quarter. The current stock performance of Bristol-Myers Squibb shows a 52-week-high of $81.43 and a 52-week-low of $62.12. Moreover, at the end of the last trading period, the closing price was at $62.28.

With a Buy rating, HSBC initiated coverage on AbbVie Inc (NYSE:ABBV). The price target seems to have been set at $167.00 for AbbVie. In the first quarter, AbbVie showed an EPS of $2.46, compared to $3.16 from the year-ago quarter. The stock has a 52-week-high of $168.11 and a 52-week-low of $130.96. At the end of the last trading period, AbbVie closed at $133.59.

Raymond James initiated coverage on Tidewater Inc (NYSE:TDW) with a Strong Buy rating. The price target for Tidewater is set to $85.00. In the first quarter, Tidewater showed an EPS of $0.23, compared to $0.28 from the year-ago quarter. The stock has a 52-week-high of $60.27 and a 52-week-low of $17.55. At the end of the last trading period, Tidewater closed at $59.65.